Pegylated interferon alpha‐2a showed no clear difference in death compared with standard interferon (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether peginterferon alpha‐2a changes all‐cause mortality Deaths during and after the treatment compared with peginterferon alpha‐2b (very low certainty).
Interferon beta‐1a showed no clear difference in death compared with placebo (low certainty).
Standard interferon showed no clear difference in death compared with placebo or control (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The intervention leads to lower death (high certainty).